Organ Transplant

Organ Transplant without organ Getting Rejected by the Body? Check out!

Healthcare Medical Equipment Pharmaceuticals

Doctors belonging to the Duke University have stated that a baby who underwent heart transplantation, that too, something tried out for the first time (with bonus technique for trying to help in preventing rejection of new organ) is thriving!

It is a known fact that thymus plays a crucial role in getting the immune system right. The doctors have heaved a sigh of relief on seeing that implantation of certain thymus tissue matching the donated Tissue and Organ Transplantation Services helps it in surviving without the need of toxic, anti-rejection medicines.

Easton Sinnamon (Asheboro, North Carolina), did receive the one-of-its-kind transplant in the last summer season when he just half a year old. However, Duke didn’t announce it before Monday after the doctors got to know that exclusively processed thymus implants function like one hopes them to function, i.e. they are producing immune cells such that they don’t look upon tot’s new heart like a foreign tissue. Dr. Joseph Turek, Duke’s head of pediatric cardiac surgery, states that doctors will ultimately try to wean the baby off immune-suppressing drugs needed post heart-transplantation.

As of now, the research is in its nascent stage. The researchers are moving around one probable method hoping to induce immune tolerance to transplant.

At the same time, Turek states that if this thing turns out to be useful, it could be extended to the other Pelvic Organ Prolapse Repair transplants as well.

Why Easton?

The doctors chose Easton as he had two distinct health problems. Firstly, he had certain defects related to functioning of the heart right from the birth. Even surgeries couldn’t relieve him of those defects. Also, he did suffer from recurrent infections, which compelled the doctors to realize that his own thymus had gone haywire.

Certain babies do not have a thymus. This does stimulate development of a part of immune system termed as “T cells”. On the other hand, Duke researchers were separately working with “Enzyyvant Therapeutics” for developing lab-grown implants of the donated thymus tissue for treating that rare disorder.

In case of Easton, the surgeons did implant his new heart when donated thymus was subject to lab testing. After 2 weeks, Easton underwent second operation for implanting the processed thymus tissue. His own thymus, that was working partially, was removed, so as to clear way to novel immune cells for taking hold.

After 6 months, Turek confirmed that the above-mentioned testing affirmed that thymus tissue had started building well-functioning new T cells in Easton.

What’s with the US FDA?

An interesting part to learn is that Duke couldn’t get approval for this experimental procedure from the US FDA as Sinnamon required processed thymus tissue implant and heart transplant – both independent of each other. However, he (himself) was a patient at university. That was the sole place wherein patients could get an access to processed thymus tissue implantation.

Turek states that success on this count will pave the way for doing away with immunosuppression medication that prove to be harsh in the long-term.

It could be inferred that the “Waiting and Watching” approach regarding effectiveness of his technique would be a viable course of action.

Leave a Reply

Your email address will not be published.